Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $50.4 million.

  • Immunocore Holdings' Shares Outstanding (Diluted Average) fell 455.37% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year decrease of 455.37%. This contributed to the annual value of $50.0 million for FY2024, which is 225.43% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Shares Outstanding (Diluted Average) is $50.4 million, which was down 455.37% from $50.3 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Shares Outstanding (Diluted Average) high stood at $52.8 million for Q3 2024, and its period low was $48.9 million during Q4 2023.
  • Over the past 3 years, Immunocore Holdings' median Shares Outstanding (Diluted Average) value was $50.2 million (recorded in 2024), while the average stood at $50.5 million.
  • Examining YoY changes over the last 5 years, Immunocore Holdings' Shares Outstanding (Diluted Average) showed a top increase of 415.54% in 2025 and a maximum decrease of 455.37% in 2025.
  • Quarter analysis of 3 years shows Immunocore Holdings' Shares Outstanding (Diluted Average) stood at $48.9 million in 2023, then grew by 2.25% to $50.0 million in 2024, then rose by 0.83% to $50.4 million in 2025.
  • Its last three reported values are $50.4 million in Q3 2025, $50.3 million for Q2 2025, and $51.9 million during Q1 2025.